87 000 Orion Corporation A shares converted into B shares
04 Dezember 2023 - 8:45AM
87 000 Orion Corporation A shares converted into B shares
ORION CORPORATION STOCK EXCHANGE RELEASE - OTHER INFORMATION
DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE4 DECEMBER 2023 at
9.45 EET
87 000 Orion Corporation A shares converted into B
shares
In accordance with Section 3 of the Articles of Association of
Orion Corporation, 87 000 A shares have been converted into 87 000
B shares. The conversion has been entered into the Trade Register
on 4 December 2023.
The total number of shares in Orion Corporation is 141,134,278
which, after the conversion, consists of 33,351,382 A shares and
107,782,896 B shares. The number of votes of the company's shares
is after the conversion 774 810 536.
Orion Corporation
| Jari
KarlsonCFO |
|
Olli HuotariSVP,
Corporate Functions |
|
Contact
person:Tuukka Hirvonen, sijoittajasuhteet, p. 010 426
2721
Publisher:Orion
CorporationCommunicationsOrionintie 1A, FI-02200 Espoo,
Finlandwww.orion.fi
Orion is a globally operating Finnish pharmaceutical company – a
builder of well-being. We develop, manufacture and market human and
veterinary pharmaceuticals and active pharmaceutical ingredients.
Orion has an extensive portfolio of proprietary and generic
medicines and self-care products. The core therapy areas of our
pharmaceutical R&D are oncology and pain. Proprietary products
developed by Orion are used to treat cancer, neurological diseases
and respiratory diseases, among others. Orion's net sales in 2022
amounted to EUR 1,341 million and the company had about 3,500
employees at the end of the year. Orion's A and B shares are listed
on Nasdaq Helsinki.
Orion (BIT:1ORNBV)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Orion (BIT:1ORNBV)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
